Skip to content

The effect of oral magnesium on glycemic and metabolic control in patients with type 1 diabetes

The effectiveness of oral magnesium administration on blood sugar, glycosylated hemoglobin, and lipid profile parameters of patients with type 1 diabetes

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20221018056231N1
Enrollment
120
Registered
2022-12-18
Start date
2022-12-22
Completion date
Unknown
Last updated
2023-02-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 1 diabetes. Type 1 diabetes mellitus without complications

Interventions

Intervention 1: Control group: For patients in this group, one gram sachets of placebo (Isfahan Faculty of Pharmacy) are prescribed for 6 months according to the standard instructions (according to th

Sponsors

Esfahan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
6 Years to 18 Years

Inclusion criteria

Inclusion criteria: Having type 1 diabetes Age range from 6 to 18 years

Exclusion criteria

Exclusion criteria: History of sensitivity to magnesium compounds Suffering from chronic diseases Use of special medicine other than insulin Use of compounds containing calcium

Design outcomes

Primary

MeasureTime frame
Blood sugar. Timepoint: Before intervention and 6 months after taking magnesium supplement. Method of measurement: Blood test.;Glycosylated hemoglobin. Timepoint: Before intervention and 6 months after taking magnesium supplement. Method of measurement: Blood test.;High-density lipoprotein cholesterol (HDL). Timepoint: Before intervention and 6 months after taking magnesium supplement. Method of measurement: Blood test.;Low-density lipoprotein cholesterol (LDL). Timepoint: Before intervention and 6 months after taking magnesium supplement. Method of measurement: Blood test.;Body mass index(BMI). Timepoint: Before intervention and 6 months after taking magnesium supplement. Method of measurement: Meters and Clinic scales.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSeyed Ebrahim Tabatabayipoor

Esfahan University of Medical Sciences

tabamohamad42@yahoo.com+98 31 3386 5016

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026